Mosrati, Mohamed Ali <br/><br/>
TERT promoter mutations and polymorphisms as prognostic factors in primary glioblastoma.  [electronic resource] 

 -  Oncotarget  Jun 2015 
 - 16663-73 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.4389  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Binding Sites--genetics<br/>Biomarkers, Tumor--genetics<br/>Female<br/>Glioblastoma--genetics<br/>Humans<br/>Interleukin-1beta--genetics<br/>Interleukin-6--genetics<br/>Isocitrate Dehydrogenase--genetics<br/>Male<br/>Middle Aged<br/>Polymorphism, Single Nucleotide--genetics<br/>Prognosis<br/>Promoter Regions, Genetic--genetics<br/>RNA, Messenger--biosynthesis<br/>Shelterin Complex<br/>Telomerase--genetics<br/>Telomere-Binding Proteins--genetics<br/>Tumor Necrosis Factor-alpha--genetics